Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB25FL1Z4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $67,919
Award facts
- Contract value 100% obligated
- $67,919.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $67,919.25 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 200-unit vials of Botox. The contract, issued on September 12, 2025, with an ultimate completion date of October 3, 2025, carries no set-aside designation. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at approximately $500 million and valid through November 2026, which enables the agency to procure pharmaceutical products to support military healthcare facilities nationwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through its comprehensive portfolio of branded and generic prescription drugs, biologics, and medical consumables. The company's federal contract history demonstrates consistent success in competing for diverse pharmaceutical products ranging from specialty medications to vaccines and injectable treatments. As a registered woman-owned small business in the System for Award Management since 2001, DMS Pharmaceutical Group leverages its status to compete effectively in federal procurement while providing direct distribution of pharmaceutical products to Department of Defense healthcare sites across the globe.
Quick answers
Who was awarded contract SPE2DB25FL1Z4?
SPE2DB25FL1Z4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FL1Z4 worth?
The government has obligated $67,919 on SPE2DB25FL1Z4.
Is contract SPE2DB25FL1Z4 an order under another contract?
Yes. SPE2DB25FL1Z4 is a delivery order under SPE2DB20D9331, an indefinite delivery contract.
Was contract SPE2DB25FL1Z4 competed?
The extent of competition for SPE2DB25FL1Z4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award